Cleared Traditional

JADE PLUS PTA Balloon Dilatation Catheter (K241025) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241025 · OrbusNeich Medical (Shenzhen) Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
57d
Days
Class 2
Risk

K241025 is an FDA 510(k) clearance for the JADE PLUS PTA Balloon Dilatation Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by OrbusNeich Medical (Shenzhen) Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on June 11, 2024 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all OrbusNeich Medical (Shenzhen) Co., Ltd. devices

Submission Details

510(k) Number K241025 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2024
Decision Date June 11, 2024
Days to Decision 57 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 125d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 154
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K241025.
Finesse Injectable™ PTA Balloon Dilatation Catheter
K241740 · Summa Therapeutics · Jul 2024
Oscar Peripheral Multifunctional Catheter system
K241711 · Biotronik, Inc. · Jul 2024
Sterling™ MONORAIL™ PTA Balloon Dilatation Catheter (H74939031404020 )
K241683 · Boston Scientific Corporation · Jul 2024
HP PTA Balloon Dilatation Catheter
K231402 · Kossel Medtech (Suzhou) Co., Ltd. · Dec 2023
Finesse™ Injectable PTA Balloon Dilatation Catheter
K230263 · Summa Therapeutics, LLC · May 2023
D·Kaptain PTA High Pressure Balloon Dilatation Catheter
K214009 · Dk Medical Technology Co., Ltd. · Apr 2023